Login Register Cart 0
Generic placeholder image

Recent Advances in Drug Delivery and Formulation

Editor-in-Chief

ISSN (Print): 2667-3878
ISSN (Online): 2667-3886

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Optimizing and Evaluating the Transdermal Permeation of Hydrocortisone Transfersomes Formulation Based on Digital Analysis of the In Vitro Drug Release and Ex Vivo Studies

Author(s): Asmae Abdelwahd and Bazigha K. Abdul Rasool*

Volume 16, Issue 2, 2022

Published on: 27 July, 2022

Page: [122 - 144] Pages: 23

DOI: 10.2174/2667387816666220608115605

open access plus

Abstract

Background: Transfersomes can be used to enhance transdermal drug delivery due to their flexibility and ability to incorporate various molecules. For example, hydrocortisone (HC), a corticosteroid, is taken by different routes and serves as immunosuppressive, anticancer, and antiallergenic; however, it is poorly absorbed by the skin.

Objective: Therefore, the current study suggested HC-loaded transfersomes as an alternative route of administration for reaching deeper skin layers or systemic circulation, to reduce the side effects of HC and improve its bioavailability.

Methods: HC transfersomes were prepared by the thin-film hydration method and characterized for their vesicular size, zeta potential, drug entrapment efficiency, elasticity, FTIR spectroscopy, in vitro drug release, ex vivo permeation, and irritancy in rabbits. The optimized formulation, F15 (containing HC 20 mg, egg phosphatidylcholine (EPC) 400 mg, and 75 mg of Span 80), was chosen because it showed the highest (p< 0.05) EE% (60.4±0.80) and optimized sustained in vitro drug release (Q8 = 87.9±0.6%).

Results: Extensive analysis of the drug release data from all formulas was performed using the DDSolver software which quantitatively confirmed the successful formulation. The Weibull equation was the best model to fit the release data compared to others, and the release mechanism was Fickian diffusion.

Conclusion: The simulated pharmacokinetic parameters showed that F15 had the highest AUC, MDT, and DE. Furthermore, F15 significantly enhanced HC permeation by 12-folds compared to the control through the excised rat's skin. The skin irritancy test has proven F15 safety and skin compatibility.

Keywords: Transfersomes, hydrocortisone, DDSolver, in vitro release, transdermal, permeation, edge activator.

« Previous Next »
Graphical Abstract

[1]
Abdul Rasool BK, Mohammed AA, Salem YY. The optimization of a dimenhydrinate transdermal patch formulation based on the quantitative analysis of in vitro release data by DDSolver through skin penetration studies. Sci Pharm 2021; 89: 33.
[http://dx.doi.org/10.3390/scipharm89030033]
[2]
Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: A review. Biomater Res 2021; 25(1): 24.
[http://dx.doi.org/10.1186/s40824-021-00226-6] [PMID: 34321111]
[3]
Gul R, Ahmed N, Shah KU, Khan GM, Rehman AU. Functionalised nanostructures for transdermal delivery of drug cargos. J Drug Target 2018; 26(2): 110-22.
[http://dx.doi.org/10.1080/1061186X.2017.1374388] [PMID: 28854819]
[4]
Benson HA. Elastic liposomes for topical and transdermal drug delivery. Methods Mol Biol 2010; 605: 77-86.
[http://dx.doi.org/10.1007/978-1-60327-360-2_4] [PMID: 20072873]
[5]
Nainwal N, Jawla S, Singh R, Saharan VA. Transdermal applications of ethosomes - a detailed review. J Liposome Res 2019; 29(2): 103-13.
[http://dx.doi.org/10.1080/08982104.2018.1517160] [PMID: 30156120]
[6]
Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020; 12(9): 855.
[http://dx.doi.org/10.3390/pharmaceutics12090855] [PMID: 32916782]
[7]
WellRx. Hydrocortisone clinical pharmacology drug Monograph. 2022. Available from: https://www.wellrx.com/hydrocortisone/monographs/
[8]
Drug Bank Online. Hydrocortisone Available from: https://go.drugbank.com/drugs/DB00741 (Accessed on: May 25, 2021).
[9]
Medline Plus. Hydrocortisone topical Available from: https://medlineplus.gov/druginfo/meds/a682793.html
[10]
Derendorf H, Möllmann H, Barth J, Möllmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharmacol 1991; 31(5): 473-6.
[http://dx.doi.org/10.1002/j.1552-4604.1991.tb01906.x] [PMID: 2050835]
[11]
Aalto-Korte K, Turpeinen M. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 1995; 133(2): 259-63.
[http://dx.doi.org/10.1111/j.1365-2133.1995.tb02625.x] [PMID: 7547394]
[12]
Wohlrab W, Lasch J, Taube KM, Wozniak KD. Hautpermeation von liposomal inkorporiertem hydrocortison. Pharmazie 1989; 44(5): 333-5.
[PMID: 2772013]
[13]
Cevc G, Blume G, Schatslein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Release 1997; 45(3): 211-26.
[http://dx.doi.org/10.1016/S0168-3659(96)01566-0]
[14]
Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 2004; 1663(1-2): 61-73.
[http://dx.doi.org/10.1016/j.bbamem.2004.01.006] [PMID: 15157608]
[15]
Al Shuwaili AH, Rasool BK, Abdulrasool AA. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm 2016; 102: 101-14.
[http://dx.doi.org/10.1016/j.ejpb.2016.02.013] [PMID: 26925505]
[16]
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010; 67(3): 217-23.
[PMID: 20524422]
[17]
Khalifa AM, Abdul Rasool BK. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine. AAPS PharmSciTech 2017; 18(8): 3064-75.
[http://dx.doi.org/10.1208/s12249-017-0780-7] [PMID: 28516414]
[18]
ASTM International. ASTM F719 - 20e1: Standard practice for testing materials in rabbits for primary skin irritation Available from: http://www.astm.org/cgi-bin/resolver.cgi?F719-81 (Accessed on: Jan 10, 2021).
[19]
Bnyan R, Khan I, Ehtezazi T, et al. Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic. J Pharm Pharmacol 2019; 71(10): 1508-19.
[http://dx.doi.org/10.1111/jphp.13149] [PMID: 31373700]
[20]
Morsi NM, Aboelwafa AA, Dawoud MHS. Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment. J Adv Res 2016; 7(5): 691-701.
[http://dx.doi.org/10.1016/j.jare.2016.07.003] [PMID: 27660724]
[21]
Qushawy M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics 2018; 10(1): 26.
[http://dx.doi.org/10.3390/pharmaceutics10010026] [PMID: 29473897]
[22]
Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. Int J Pharm 2020; 573: 118817.
[http://dx.doi.org/10.1016/j.ijpharm.2019.118817] [PMID: 31678520]
[23]
Jangdey MS, Gupta A, Saraf S, Saraf S. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: In vitro evaluation. Artif Cells Nanomed Biotechnol 2017; 45(7): 1452-62.
[http://dx.doi.org/10.1080/21691401.2016.1247850] [PMID: 28050929]
[24]
Mandal U, Mahmood S, Taher M. Experimental design and optimisation of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Int J Nanomedicine 2014; 2014: 4331.
[http://dx.doi.org/10.2147/IJN.S65408]
[25]
Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers. AAPS PharmSciTech 2013; 14(1): 133-40.
[http://dx.doi.org/10.1208/s12249-012-9904-2] [PMID: 23242556]
[26]
Wikipedia. The free encyclopedia: Zeta potential Available from: https://en.wikipedia.org/wiki/Zeta_potential
[27]
Kassem MA, Aboul-Einien MH, El Taweel MM. Dry gel containing optimized felodipine-loaded transferosomes: A promising transdermal delivery system to enhance drug bioavailability. AAPS PharmSciTech 2018; 19(5): 2155-73.
[http://dx.doi.org/10.1208/s12249-018-1020-5] [PMID: 29714001]
[28]
Abdelmonem R, Hamed RR, Abdelhalim SA, ElMiligi MF, El-Nabarawi MA. Formulation and characterization of cinnarizine targeted aural transfersomal gel for vertigo treatment: A pharmacokinetic study on rabbits. Int J Nanomedicine 2020; 15: 6211-23.
[http://dx.doi.org/10.2147/IJN.S258764] [PMID: 32904111]
[29]
Salama HA, Mahmoud AA, Kamel AO, Abdel Hady M, Awad GA. Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res 2012; 22(4): 336-45.
[http://dx.doi.org/10.3109/08982104.2012.700460] [PMID: 22881283]
[30]
Darusman F, Raisya R, Priani SE. Development, characterization, and performance evaluation of transfersome gel of ibuprofen as a transdermal drug delivery system using nanovesicular carrier. Drug Invention Today 2018; 10(5): 6.
[31]
Al-Mahallawi AM, Khowessah OM, Shoukri RA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: In-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm 2014; 472(1-2): 304-14.
[http://dx.doi.org/10.1016/j.ijpharm.2014.06.041] [PMID: 24971692]
[32]
Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 2006; 3(6): 727-37.
[http://dx.doi.org/10.1517/17425247.3.6.727] [PMID: 17076595]
[33]
Gupta A, Aggarwal G, Singla S, Arora R. Transfersomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline: Development, characterization, and performance evaluation. Sci Pharm 2012; 80(4): 1061-80.
[http://dx.doi.org/10.3797/scipharm.1208-02] [PMID: 23264950]
[34]
Kobryń J, Sowa S, Gasztych M, Dryś A, Musiał W. Influence of hydrophilic polymers on the factor in Weibull equation applied to the release kinetics of a biologically active complex of aesculus hippocastanum. Int J Polym Sci 2017; 2017: 3486384.
[http://dx.doi.org/10.1155/2017/3486384]
[35]
Wojcik-Pastuszka D, Krzak J, Macikowski B, Berkowski R, Osiński B, Musiał W. Evaluation of the release kinetics of a pharmacologically active substance from model intra-articular implants replacing the cruciate ligaments of the knee. Materials (Basel) 2019; 12(8): 1202.
[http://dx.doi.org/10.3390/ma12081202] [PMID: 31013801]
[36]
Vueba ML, Luís AE, Batista de Carvalho LAE, Pina ME. Relaxation versus diffusion on the diclofenac sodium release from matrix tablets containing hydroxypropylmethylcellulose and/or chitosan. Afr J Pharmacy Pharmacol 2013; 7(3): 83-97.
[http://dx.doi.org/10.5897/AJPP12.710]
[37]
Rafiee MH, Abdul Rasool BK. An overview of microparticulate drug delivery system and its extensive therapeutic applications in diabetes. Adv Pharm Bull 2022. [Epub ahead of prit].
[http://dx.doi.org/10.34172/apb.2022.075]
[38]
Ahad A, Al-Saleh AA, Al-Mohizea AM, et al. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm J 2017; 25(7): 1040-6.
[http://dx.doi.org/10.1016/j.jsps.2017.01.006] [PMID: 29158713]
[39]
Dudhipala N, Phasha Mohammed R, Adel Ali Youssef A, Banala N. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation. Drug Dev Ind Pharm 2020; 46(8): 1334-44.
[http://dx.doi.org/10.1080/03639045.2020.1788069] [PMID: 32598194]

Rights & Permissions Print Cite
Article Metrics
12
© 2024 Bentham Science Publishers | Privacy Policy